Skip to main content
. Author manuscript; available in PMC: 2016 May 14.
Published in final edited form as: Brain Res. 2014 Oct 24;1607:94–107. doi: 10.1016/j.brainres.2014.10.031

Figure 1.

Figure 1

Use of biomarkers in ALS drug development and clinical trials. Biomarker discovery and validation efforts incorporate various model systems and patient population, using –omics based technologies and imaging. These biomarkers are used to identify pathways to target for drug development, selection of patients for clinical trials, target engagement of the drug and determining efficacy within the patients.